|
Tsai, Max; Lu, Ze; Wientjes, M Guillaume et al. (2013) Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics. J Control Release 172:737-44
|
|
Hu, Leijun; Wientjes, M Guillaume; Li, Jing et al. (2010) Bladder tissue pharmacokinetics of intravesical mitomycin C and suramin in dogs. AAPS J 12:586-91
|
|
Lu, Ze; Wang, Jie; Wientjes, M Guillaume et al. (2010) Intraperitoneal therapy for peritoneal cancer. Future Oncol 6:1625-41
|
|
Lu, Ze; Tsai, Max; Lu, Dan et al. (2008) Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer. J Pharmacol Exp Ther 327:673-82
|
|
Villalona-Calero, M A; Otterson, G A; Wientjes, M G et al. (2008) Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study. Ann Oncol 19:1903-9
|
|
Tsai, Max; Lu, Ze; Wang, Jie et al. (2007) Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel. Pharm Res 24:1691-701
|
|
Chen, Danny; Song, Sae Heum; Wientjes, M Guillaume et al. (2006) Nontoxic suramin as a chemosensitizer in patients: dosing nomogram development. Pharm Res 23:1265-74
|
|
Wientjes, M Guillaume; Zheng, Jenny H; Hu, Leijun et al. (2005) Intraprostatic chemotherapy: distribution and transport mechanisms. Clin Cancer Res 11:4204-11
|
|
Xin, Yan; Lyness, Greg; Chen, Danny et al. (2005) Low dose suramin as a chemosensitizer of bladder cancer to mitomycin C. J Urol 174:322-7
|
|
Yeh, Teng Kuang; Lu, Ze; Wientjes, M Guillaume et al. (2005) Formulating paclitaxel in nanoparticles alters its disposition. Pharm Res 22:867-74
|
Showing the most recent 10 out of 64 publications
